Private
As both the public’s and lawmakers’ concerns over the spread of COVID-19 continue to mount, Inovio Pharmaceuticals, Inc. announced it will accelerate its set timeline for the development of a DNA vaccine targeting the virus.
The vaccine has been underway since January when Chinese... Read More »
Lockheed Martin recently highlighted a pair of F-35 aircraft milestones, one related to delivery and the other to logged flight hours.
Lockheed Martin and the F-35 Joint Program Office have delivered the 500th F-35, and last month, the F-35 enterprise surpassed 250,000 flight hours.
“These... Read More »
The World Health Organization (WHO) this week warned that severe disruption of the global supply of personal protective equipment (PPE) is endangering lives already at risk by COVID-19 and other infectious diseases as reports of equipment hoarding, crisis profiteering, and general misuse have come... Read More »
Right-wing extremists were responsible for a majority of extremist-related murders in the United States last year, according to a report by the Anti-Defamation League (ADL).
Of the 42 extremist-related murders in the nation last year, 38 were committed by individuals subscribing to various... Read More »
Two government agencies said Southwest Valley Constructors Co. has secured a contract to build 15 miles of new Rio Grande Valley (RGV) Sector border wall.
Customs and Border Protection (CBP) and U.S. Army Corps of Engineers (USACE) officials announced the contract, valued at $179,580,000,... Read More »
The U.S. Department of Homeland Security (DHS) Science and Technology Directorate (S&T) announced its third Biometric Technology Rally this week, allowing submitters to show off improved biometric recognition capabilities.
Those capabilities could improve security and use of checkpoint... Read More »
A new policy issued by the U.S. Food and Drug Administration (FDA) this week means to expedite U.S. diagnostic capabilities related to the novel coronavirus, COVID-19, by allowing specific labs to immediately utilize related tests they have developed and validated.
This builds on an Emergency... Read More »
The new open access journal of the American College of Emergency Physicians (ACEP), the JACEP Open, is kicking things off with dual analyses of COVID-19 -- both its transmission risk factors and the public health concerns such outbreaks spur.
To date, notes the article Novel Coronavirus 2019:... Read More »
Raytheon Company is teaming up with IronNet Cybersecurity to develop cyber solutions for the defense of operational and information technology (OT/IT) systems.
These solutions would integrate security services with advanced analysis and threat sharing tools through IronNet's collective defense... Read More »
The U.S. Marine Corps recently awarded BAE Systems a $113.5 million contract for 26 additional Amphibious Combat Vehicles (ACV) under the Low-Rate Initial Production phase of the program.
BAE Systems and Iveco Defence Vehicles are replacing the corps’ Assault Amphibious Vehicles with ACV, a... Read More »
Under the newly launched Technology Accelerator Challenge, the National Institutes of Health (NIH) is offering $1 million for those capable of designing and developing handheld, digital technologies capable of detecting and diagnosing high impact diseases.
Bolstered by support from the Bill &... Read More »
Harvard University scientists will work with researchers from China to develop coronavirus therapies and treatments designed to prevent new infections and alleviate existing ones.
The effort will be led by Harvard Medical School Dean George Q. Daley, working with colleagues from the Harvard T.H.... Read More »
The National Institute of Allergy and Infectious Diseases (NIAID) has begun a clinical trial of experimental drug remdesivir in Nebraska, to see its potential abilities to treat the novel coronavirus, COVID-19.
“We urgently need a safe and effective treatment for COVID-19. Although remdesivir... Read More »
While the weekend sent global fears of a COVID-19 pandemic spiking, Biomedical Advanced Research and Development Authority (BARDA) Director Rick Bright touted the speed at which public-private partnerships have acted on medical countermeasures.
BARDA has expanded agreements with three companies... Read More »
In three weeks, researchers at Australia’s University of Queensland have produced a vaccine candidate for the novel coronavirus, COVID-19, and have moved it to further development.
Part of the larger Coalition for Epidemic Preparedness Innovations (CEPI) rapid response program, the effort has... Read More »
In an effort to push forward research that could yield a novel coronavirus (COVID-19) vaccine, the Tulane Primate Research Center (TNPRC) announced plans to develop a nonhuman primate model focused on the disease’s clinical progression, transmission, and effects on aging populations.
The... Read More »
The Jack Ma Foundation recently awarded four research teams at Columbia University $2.1 million for their efforts to identify potential antiviral drugs and antibiotics for use against the novel coronavirus (COVID-19) outbreak.
The Chinese-based foundation awarded the funds to Columbia with the... Read More »
According to Dr. Amos Danielli, of the Alexander Kofkin Faculty of Engineering at Bar-Ilan University, 15 minutes may be all it takes to diagnose cases of the novel coronavirus (COVID-19), thanks to a new diagnostic technology.
While existing methods of diagnosing COVID-19 take around one hour,... Read More »
In March, the Coalition for Epidemic Preparedness (CEPI) and the International Alliance for Biological Standardization (IABS) will co-host a Brussels-based meeting on the licensing of vaccine platform technologies, to consider the potential benefits of the new registration procedure.
This, the... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) has announced it is teaming up with Sanofi Pasteur to mix the authority’s expertise and funds with Sanofi’s egg-free, recombinant DNA platform to try and produce a novel coronavirus (COVID-19) vaccine... Read More »
The First Responder Network Authority (FirstNet Authority) is bringing enhancements to the FirstNet network in New Hampshire ahead of schedule.
AT&T and Gov. Chris Sununu recently hosted an event to celebrate.
FirstNet is a nationwide, wireless communications platform for first responders... Read More »
A new milestone in the fight against Ebola was achieved last week with the announcement that Merck’s injectable vaccine, Ervebo, has been licensed for use against Ebola in four nations: the Democratic Republic of the Congo (DRC), Burundi, Ghana, and Zambia.
Additional registrations of the... Read More »
Officials at the National Institute of Allergy and Infectious Diseases (NIAID) authored an article in The Journal of Infectious Diseases that updates the institute’s progress on tuberculosis (TB) research.
Specifically, the article summarizes recent progress in improved TB diagnostics,... Read More »
Since the rapid outbreak of the novel coronavirus (COVID-19) on Wuhan, China, and beyond, numerous governments have restricted travel to and from China, but a new university-run study reminds one and all that the effectiveness of travel bans remains unknown.
While the World Health Organization... Read More »
Wuhan, the epicenter of the coronavirus (COVID-19) epidemic, is also a production hub for pharmaceutical ingredients for the United States. As the virus spreads throughout China, the U.S. drug supply remains vulnerable to reduced production and export of essential materials. There are 400 drug... Read More »
Implementing autonomous-vehicle technology would make U.S. Army convoys safer by reducing the number of service members needed to operate the vehicles, according to a study by RAND Corp., a research organization that develops solutions to public policy challenges.
“With current technology,... Read More »
U.S. Defense Advanced Research Projects Agency's (DARPA) Defense Sciences Office awarded a contract to BAE Systems to develop technology to help detect weapons of mass destruction (WMD) activity.
The analytics technology will leverage multiple data sources and uses data fusion, adversary... Read More »
Over the course of a two-day forum this week, the World Health Organization (WHO) brought together leading health experts and major research funders to discuss COVID-19.
They addressed the novel coronavirus from all angles: assessing current knowledge, identifying gaps, and collaborating on the... Read More »
The U.S. Department of Health and Human Services (HHS) intends to add a new layer to its relationship with Janssen Research & Development as part of efforts to contain COVID-19 -- the 2019 novel coronavirus -- through shared R&D costs on the company's investigational vaccine.
The Biomedical... Read More »
The U.S. Department of Health and Human Services created the first Foundry for American Biotechnology to produce technological solutions to enhance medical care and respond to health security threats.
The Foundry will be located in Manchester, N.H., and managed by the Advanced Regenerative... Read More »
In the wake of the global coronavirus (COVID-19) outbreak, policymakers and the public are asking what more could have been done to prevent the spread of that disease.
Public health officials participated on Monday at the Hudson Institute in a panel discussion to answer that question. The talk,... Read More »
Researchers at the University of Oklahoma received a $730,000 grant from the National Aeronautics and Space Administration (NASA) last week, to aid their investigations of emerging diseases -- research made all the more timely by the emergence of the Chinese novel coronavirus (2019-nCoV).
The... Read More »
The second wave of Americans arrived in California on Wednesday, traveling from Wuhan, China, the epicenter of the coronavirus (2019-nCoV) epidemic. They will spend days on military bases in quarantine as public health officials determine if there are any cases of the virus and to treat those... Read More »
An existing relationship between the U.S. Office of the Assistant Secretary for Preparedness and Response (ASPR) and Regeneron Pharmaceuticals, Inc. will be extended under a new arrangement to develop a treatment for the novel coronavirus (2019-nCoV).
"Emerging infectious diseases can present... Read More »
Pattern Bioscience was awarded $6.8 million in funding to develop a test to diagnose drug-resistant infections quickly.
The rapid identification and antimicrobial susceptibility test (ID/AST) will provide health professionals with information about which pathogen is causing the infection and... Read More »
